SCHEMBL624633

SCHEMBL624633

CCOC(=O)C1CCCN(c2nn3c(-c4cnc(N)c(C(F)(F)F)c4)cnc3s2)C1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.47
F10 P00742 1/20 0.43
KCNH2 Q12809 4/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 2/20 0.42
TP53 P04637 2/20 0.42
HSD17B10 Q99714 1/20 0.42
SHMT2 P34897 1/20 0.41
JAK2 O60674 1/20 0.41
JAK3 P52333 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625222 0.88 PIK3CA (0.48) PIK3CAKCNH2
SCHEMBL624634 0.88 MAPT (0.52) MAPTTP53LMNA
SCHEMBL625177 0.86 PIK3CA (0.49) PIK3CAKCNH2MAPT
SCHEMBL626391 0.82 PIK3CA (0.48) PIK3CAKCNH2
SCHEMBL625018 0.82 PIK3CA (0.51) PIK3CAKCNH2
SCHEMBL625201 0.81 PIK3CA (0.48) PIK3CAKCNH2
SCHEMBL624865 0.81 PIK3CA (0.49) PIK3CAKCNH2
SCHEMBL626006 0.81 PIK3CA (0.46) PIK3CAKCNH2MAPTTP53LMNA
SCHEMBL625746 0.81 PIK3CA (0.54) PIK3CAKCNH2
SCHEMBL623998 0.80 PIM1 (0.51) KCNH2MAPTKDM4ETP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed